SCHEMBL24310676

SCHEMBL24310676

CN/C=C(\C=N)SNc1nc(Oc2ccccc2C)c(OC(C)C)c(-c2ccccc2C)n1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24309395 0.90 — —
SCHEMBL24309385 0.83 — —
SCHEMBL24310694 0.78 — —
SCHEMBL24310113 0.75 — —
SCHEMBL24309805 0.73 — —
SCHEMBL24310725 0.71 MAP3K7 (0.30) —
SCHEMBL24309724 0.69 — —
SCHEMBL24310429 0.69 F10 (0.37) —
SCHEMBL24310323 0.68 — —
SCHEMBL24310674 0.66 HTR1A (0.40) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022076627-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMACEUTICALS INCORPORATED (US) 2022-04-14 — — WO disclosed
Send feedback